Gut microbiome analysis in neuromyelitis optica reveals overabundance of Clostridium perfringens

Por Cree, Bruce A. C., Spencer, Collin M., Varrin‐Doyer, Michel, Baranzini, Sergio E., Zamvil, Scott S.
Publicado no Ann Neurol (2016)

Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate

Por Spencer, Collin M., Crabtree-Hartman, Elizabeth C., Lehmann-Horn, Klaus, Cree, Bruce A.C., Zamvil, Scott S.
Publicado no Neurol Neuroimmunol Neuroinflamm (2015)

Aquaporin 4-Specific T Cells in Neuromyelitis Optica Exhibit a Th17 Bias and Recognize Clostridium ABC Transporter

Por Varrin-Doyer, Michel, Spencer, Collin M, Schulze-Topphoff, Ulf, Nelson, Patricia A, Stroud, Robert M, C Cree, Bruce A, Zamvil, Scott S
Publicado em 2012

Glatiramer acetate treatment negatively regulates type I interferon signaling

Por Molnarfi, Nicolas, Prod'homme, Thomas, Schulze-Topphoff, Ulf, Spencer, Collin M., Weber, Martin S., Patarroyo, Juan C., Lalive, Patrice H., Zamvil, Scott S.
Publicado no Neurol Neuroimmunol Neuroinflamm (2015)

CNS accumulation of regulatory B cells is VLA-4-dependent

Por Lehmann-Horn, Klaus, Sagan, Sharon A., Winger, Ryan C., Spencer, Collin M., Bernard, Claude C.A., Sobel, Raymond A., Zamvil, Scott S.
Publicado no Neurol Neuroimmunol Neuroinflamm (2016)

Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls

Por Tremlett, Helen, Fadrosh, Douglas W., Faruqi, Ali A., Hart, Janace, Roalstad, Shelly, Graves, Jennifer, Spencer, Collin M., Lynch, Susan V., Zamvil, Scott S., Waubant, Emmanuelle
Publicado no BMC Neurol (2016)

Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression

Por Varrin-Doyer, Michel, Pekarek, Kara L., Spencer, Collin M., Bernard, Claude C.A., Sobel, Raymond A., Cree, Bruce A.C., Schulze-Topphoff, Ulf, Zamvil, Scott S.
Publicado no Neurol Neuroimmunol Neuroinflamm (2016)

MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS

Por Varrin-Doyer, Michel, Shetty, Aparna, Spencer, Collin M., Schulze-Topphoff, Ulf, Weber, Martin S., Bernard, Claude C.A., Forsthuber, Thomas, Cree, Bruce A.C., Slavin, Anthony J., Zamvil, Scott S.
Publicado em 2014

Therapeutic Decisions In Multiple Sclerosis: Moving Beyond Efficacy

Por Brück, Wolfgang, Ralf, Gold, Lund, Brett T., Celia, Oreja-Guevara, Prat, Alexandre, Spencer, Collin M., Steinman, Lawrence, Mar, Tintoré, Vollmer, Timothy, Weber, Martin S., Weiner, Leslie P., Ziemssen, Tjalf, Zamvil, Scott S.
Publicado em 2013

Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2

Por Schulze-Topphoff, Ulf, Varrin-Doyer, Michel, Pekarek, Kara, Spencer, Collin M., Shetty, Aparna, Sagan, Sharon A., Cree, Bruce A. C., Sobel, Raymond A., Wipke, Brian T., Steinman, Lawrence, Scannevin, Robert H., Zamvil, Scott S.
Publicado no Proc Natl Acad Sci U S A (2016)

Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4

Por Sagan, Sharon A., Winger, Ryan C., Cruz-Herranz, Andrés, Nelson, Patricia A., Hagberg, Sarah, Miller, Corey N., Spencer, Collin M., Ho, Peggy P., Bennett, Jeffrey L., Levy, Michael, Levin, Marc H., Verkman, Alan S., Steinman, Lawrence, Green, Ari J., Anderson, Mark S., Sobel, Raymond A., Zamvil, Scott S.
Publicado no Proc Natl Acad Sci U S A (2016)